Home / Brand archive
30 reported ongoing
46 records in this archive. Latest source date May 1, 2026.
FDA enforcement status can lag behind the recall lifecycle. An empty search or a reported termination is not a personal product-safety determination.
Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.
Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.
Class IIIReported ongoing
Distribution: USA Nationwide
Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.
Class IIIReported ongoing
Distribution: USA Nationwide
Failed tablet specifications.
Class IIReported ongoing
Distribution: U.S. Nationwide
Defective container: card seal defects (weak/non-existent seals), leading to the tablets falling out of their cavities.
Class IIReported ongoing
Distribution: Nationwide in the USA
Failed Impurities/Degradation Specification: presence of N-nitroso Prazosin impurity C above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit
Class IIReported ongoing
Distribution: Nationwide within the United States
Failed Impurities/Degradation Specification: presence of N-nitroso Prazosin impurity C above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit
Class IIReported ongoing
Distribution: Nationwide within the United States
Failed Impurities/Degradation Specification: presence of N-nitroso Prazosin impurity C above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit
Class IIReported ongoing
Distribution: Nationwide within the United States
CGMP Deviations: The recalling firm filed for Chapter 11 on September 30, 2024. As a result, it cannot monitor the quality program and hence cannot assure that products meet the identity, strength, quality, and purity characteristics that they are purported...
Class IIReported ongoing
Distribution: Nationwide within the United States
Failed Dissolution Specifications.
Class IIReported ongoing
Distribution: Nationwide in the USA.
Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging at the manufacturing site, was detected with presence of a micro-organism. No micro-organism was detected on any tablets.
Class IIReported ongoing
Distribution: Nationwide in the USA
Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging at the manufacturing site, was detected with presence of a micro-organism. No micro-organism was detected on any tablets.
Class IIReported ongoing
Distribution: Nationwide in the USA
Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging at the manufacturing site, was detected with presence of a micro-organism. No micro-organism was detected on any tablets.
Class IIReported ongoing
Distribution: Nationwide in the USA
Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging at the manufacturing site, was detected with presence of a micro-organism. No micro-organism was detected on any tablets.
Class IIReported ongoing
Distribution: Nationwide in the USA
CGMP Deviations: The recalling firm filed for Chapter 11 in September 2024. As a result, it cannot monitor the quality program and hence cannot assure that products meet the identity, strength, quality, and purity characteristics that they are purported or ...
Class IIReported ongoing
Distribution: Nationwide
cGMP deviations
Class IIReported ongoing
Distribution: Nationwide in the USA
Lack of assurance of sterility. Bacterial contamination detected in some media fill units
Class IIReported ongoing
Distribution: Nationwide in the USA
Lack of assurance of sterility. Bacterial contamination detected in some media fill units
Class IIReported ongoing
Distribution: Nationwide in the USA
Lack of assurance of sterility. Bacterial contamination detected in some media fill units
Class IIReported ongoing
Distribution: Nationwide in the USA
cGMP Deviations: Received notification from their supplier requesting they perform a recall due to the fact they repackaged the product.
Class IIReported terminated
Distribution: USA nationwide.
Presence of Foreign Tablets/Capsules
Class IIReported ongoing
Distribution: Nationwide within the United States
These examples come from this result page and are not a ranking of every recall reason.
This archive contains 46 records, including 30 with agency-reported ongoing status. The status field can be incomplete or stale. Open the current official notice and match your exact product.
Compare the product, firm and lot, date, model or serial identifiers with the notice. Use the label-check guide if you need help locating an identifier.
A name is a search match. The agency notice sets the affected products and identifiers. Do not assume that every item with the same name or brand belongs to the recall.
This search has source and keyword limits. Missing records or a missing lot code do not establish that a product is unaffected. Check source coverage and the agency's current notices.
Use monthly archives or the local search. The initial import covers records dated from October 2021 where available; each source's actual first and latest dates appear on the coverage page.